LSTA · Lisata Therapeutics, Inc. · Investor Relations
$1.64
-0.26 (-13.68%)
At close · Sep 10
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$14.78M
Shares
9.01M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-11-06 | Lisata Therapeutics 3rd Quarter 2025 Financial Results and Business Update Conference Call | Earnings call |
| 2025-10-20 | LD Micro Main Event XIX | Webcast |
| 2025-09-05 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-08-07 | Lisata Therapeutics 2nd Quarter 2025 Financial Results and Business Update Conference Call | Earnings call |
| 2025-06-17 | 2025 BIO International Convention | Event |
| 2025-05-08 | Lisata Therapeutics 1st Quarter 2025 Financial Results and Business Update Conference Call | Earnings call |
| 2025-02-27 | Full Year 2024 Financial Results and Business Update Conference Call | Earnings call |
| 2025-02-10 | 2025 BIO CEO & Investor Conference | Conference |
| 2025-01-22 | 2025 Sequire Investor Summit | Event |
Source: https://ir.lisata.com/
Key facts
CIK
320017
CUSIP
128058302
13F (30d)
21 filings
21 filers
Visit website
Investor relations